ScholarIQanswers from OpenAlex

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

PaperCitations, authors & open-access status

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay have?

ScholarIQcitation count

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay has 311 citations in the OpenAlex counts ScholarIQ stores.

When was Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay published?

ScholarIQyear

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay has 1994 year in the ScholarIQ index.

What is the open-access status of Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay?

ScholarIQoa status

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay has closed oa status in the ScholarIQ index.

What is the DOI of Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay?

ScholarIQdoi

The DOI for Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay is on the source record.

What is the PMID of Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay?

ScholarIQpmid

The PMID for Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay is on the source record.

What is the OpenAlex record for Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay?

ScholarIQopenalex

The OpenAlex for Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial